Use of a genetic variant related to circulating factor Xa levels to proxy the effect of factor Xa Inhibition on cardiovascular outcomes
File(s)CIRCGEN.120.003061.pdf (145.72 KB)
Published version
Author(s)
Gill, Dipender
Burgess, S
Type
Journal Article
Date Issued
2020-10
Date Acceptance
2020-07-01
Citation
Circulation: Genomic and Precision Medicine, 2020, 13, pp.551-553
ISSN
2574-8300
Publisher
American Heart Association
Start Page
551
End Page
553
Journal / Book Title
Circulation: Genomic and Precision Medicine
Volume
13
Copyright Statement
© 2020 The Authors. Circulation Genomic and Precision Medicine is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.
License URL
Identifier
https://www.ahajournals.org/doi/10.1161/CIRCGEN.120.003061
Subjects
Mendelian randomization analysis
cardiovascular disease
coronary artery disease
serine protease
Publication Status
Published online
Date Publish Online
2020-08-13